Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells.
about
Immune targeting of cancer stem cells in gastrointestinal oncologyCancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic StrategiesTumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growthNew targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancersProstaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functionsM2-polarized macrophages in keratocystic odontogenic tumor: relation to tumor angiogenesis.Downregulation of COMMD1 by miR-205 promotes a positive feedback loop for amplifying inflammatory- and stemness-associated properties of cancer cells.Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling.Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies.Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer.Small cell lung cancer: Recruitment of macrophages by circulating tumor cells.Induction of protumoral CD11c(high) macrophages by glioma cancer stem cells through GM-CSF.Role of cancer stem cell-associated inflammation in creating pro-inflammatory tumorigenic microenvironments.Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts.Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment.Interplay between inflammatory tumor microenvironment and cancer stem cells.
P2860
Q26749015-03D23DBA-2FC8-412C-92CF-93A43B4F06F9Q26765342-BD7A4486-57C4-498A-8B5D-7A2DE5C66BD3Q33770873-C71D40ED-EBED-4ADF-82B7-4C8ADDCCAEAEQ34706060-646A64AE-78A9-40B7-B5B8-389ABBA1270EQ35713568-C9B37AE2-2A4B-4682-B96E-291ED1F318EEQ36216692-11B7A2B6-C3AD-40B7-B499-B2AD9B35808AQ36799298-363BAC59-5915-4F77-8322-ED2A260F9BA6Q37575463-BF76951B-6EAB-4987-8BD6-09A0802609C7Q38472322-6AEBB515-C06F-45EE-B465-273C6687DF3BQ38514906-DE665B84-7CA2-434B-9A7B-4350B55BA9B1Q38773484-A9A31E0F-9641-4CD7-870F-0C988D0CEE5BQ38799821-B79AD665-C70A-45B0-B7D0-748BC9852E5BQ42031084-54C9EF05-E662-49FD-BDF1-B4795FB0FBF7Q49231498-DB59089B-7EFC-44B9-9FAA-BC0FB18925D4Q52571378-76D02647-1057-4BE6-BB5D-C8B27D2A6D47Q55375210-B7D0F1DA-1F52-4B67-B3F0-157633EE3994
P2860
Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Cancer stem-like cells derived ...... ime tumorigenic myeloid cells.
@en
Cancer stem-like cells derived ...... ime tumorigenic myeloid cells.
@nl
type
label
Cancer stem-like cells derived ...... ime tumorigenic myeloid cells.
@en
Cancer stem-like cells derived ...... ime tumorigenic myeloid cells.
@nl
prefLabel
Cancer stem-like cells derived ...... ime tumorigenic myeloid cells.
@en
Cancer stem-like cells derived ...... ime tumorigenic myeloid cells.
@nl
P2093
P1433
P1476
Cancer stem-like cells derived ...... rime tumorigenic myeloid cells
@en
P2093
Akihiro Yoneda
Hirotoshi Dosaka-Akita
Ichiro Kinoshita
Masahisa Jinushi
Tsunaki Yamashina
P304
P356
10.1158/0008-5472.CAN-13-2169
P407
P577
2014-03-17T00:00:00Z